独立验证胶样囊肿风险评分对第三脑室胶样囊肿患者症状与脑积水的预测作用
本研究回顾性纳入156例第三脑室胶样囊肿患者,独立验证胶样囊肿风险评分(CCRS)的预测价值。CCRS在各评分水平均可分层有症状患者与脑积水患者(P < 0.001),从CCRS 2分到5分,有症状患者比例由13%升至100%,脑积水患者比例由8%升至83%;CCRS预测有症状胶样囊肿的曲线下面积为0.914,预测脑积水的曲线下面积为0.892。
要点
- CCRS在各评分水平均可分层有症状与脑积水患者(P < 0.001)。
- CCRS由2分升至5分,有症状比例由13%升至100%,脑积水比例由8%升至83%。
- CCRS预测有症状胶样囊肿的AUC为0.914,预测脑积水的AUC为0.892。
核心结论
- 数据分析验证了CCRS对有症状状态和脑积水的预测价值,并支持将CCRS用于风险分层和临床决策。
研究设计与样本
- 回顾性研究,从机构收费记录和放射学报告档案中识别第三脑室胶样囊肿患者,排除无确诊第三脑室胶样囊肿或未行脑磁共振成像者,通过回顾性病历审查收集数据,共156例患者符合纳入和排除标准。
主要发现
- 在本队列中,CCRS在所有评分水平上均可分层有症状患者和脑积水患者(P < 0.001)。
- 从CCRS 2分到5分,有症状患者比例从13%升至100%,脑积水患者比例从8%升至83%。
- 简单逻辑回归显示,CCRS总分、头痛、轴位直径、液体衰减反转恢复高信号和风险区域均对有症状状态和脑积水有高度预测作用(P < 0.001)。
- CCRS的逻辑回归受试者工作特征曲线显示,有症状胶样囊肿的曲线下面积为0.914,伴脑积水的胶样囊肿的曲线下面积为0.892。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Colloid Cyst Risk Score (CCRS) was devised to identify patients with symptomatic colloid cyst and stratify risk of hydrocephalus. The CCRS considers patient age, presence of headache, colloid cyst diameter, fluid-attenuated inversion recovery hyperintensity, and location within the third ventricle. OBJECTIVE: The purpose of this study was to independently evaluate the validity of the CCRS. METHODS: Patients with a colloid cyst of the third ventricle were identified retrospectively from institutional billing records and radiology report archives. Patients without a confirmed diagnosis of colloid cyst of the third ventricle or magnetic resonance imaging of the brain were excluded. Data were collected via retrospective chart review. RESULTS: One hundred and fifty-six patients met inclusion and exclusion criteria. In our cohort, the CCRS stratified symptomatic patients and patients with hydrocephalus across all scores (P < 0.001). From CCRS 2 to 5, the percentage of symptomatic patients increased from 13% to 100%, whereas the percentage of patients with hydrocephalus increased from 8% to 83%. Simple logistic regression showed that total CCRS, headache, axial diameter, fluid-attenuated inversion recovery hyperintensity, and risk zone were all highly predictive of symptomatic status and hydrocephalus (P < 0.001). Logistic regression with receiver operating curves for the CCRS showed an area under the curve of 0.914 for symptomatic colloid cysts and an area under the curve of 0.892 for colloid cysts with hydrocephalus. CONCLUSIONS: Our data analysis validates the predictive value of the CCRS for both symptomatic status and hydrocephalus and supports the use of the CCRS in risk stratification and clinical decision making.
引用
- Alford EN, Rotman LE, Shank CD, et al. Independent Validation of the Colloid Cyst Risk Score to Predict Symptoms and Hydrocephalus in Patients with Colloid Cysts of the Third Ventricle. World Neurosurg. 2019. PMID: 31706971. doi:10.1016/j.wneu.2019.10.188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。